Zura Bio Limited (ZURA) Stock Overview
Explore Zura Bio Limited’s financial performance, market position, analyst ratings, and future outlook.
Zura Bio Limited (ZURA)
Key Financials
Key Financials
Market Cap
119.4M
P/E Ratio
-3.74
EPS (TTM)
$-1.09
ROE
-0.54%
ZURA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Zura Bio Limited (NASDAQ: ZURA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Zura Bio Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ZURA on the NASDAQ shows an RSI of 49.43, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $6.69 for the NASDAQ listing.
Key metrics behind Zura Bio Limited's NASDAQ-traded stock include a P/E ratio of -3.74 and a market capitalization of 119.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ZURA on the NASDAQ.